RiboMarker-NextGen Biomarker Discovery SANTA CRUZ, CA, UNITED STATES — RealSeq Biosciences, a pioneer in RNA-based diagnostics, today announced it has received a Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) (FAIN# R44HG013284; Federal Award Date: August 15, 2025). This highly competitive award provides multi-year, non-dilutive funding to accelerate […]

New formats redefine molecular assay development by cutting refrigeration costs, simplifying logistics, and ensuring uncompromised performance at room temperature. CINCINNATI — The Life Science division of Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, today announced the launch of the industry’s first liquid qPCR master mixes proven stable for over […]

San Diego, CA – Genesee Scientific, a leading provider of high-quality, value-driven lab essentials, today announced the acquisition of Jade Scientific, a Michigan-based distributor recognized for its extensive offering of chemicals and consumables to clinical reference, pharma/biotech, and environmental labs nationwide. This strategic acquisition marks a significant milestone in Genesee’s growth journey. Together, the two companies will […]

Researchers aim to identify cellular circuit mechanisms and generate a dataset to fuel AI-driven foundational research of lung biology MUNICH, Germany and SEATTLE, United States — Helmholtz Munich and Parse Biosciences today announced a strategic partnership to generate the world’s broadest lung disease perturbation atlas, powered by Parse Biosciences’ GigaLab platform. Using a human lung ex-vivo tissue […]

BALTIMORE — #ELN—Sapio Sciences, the science-awareTM lab informatics platform, today announced a strategic partnership with Ultima Genomics. The collaboration will make multi-omics workflows more accessible and streamlined for researchers by integrating Sapio’s AI-powered lab informatics solutions with Ultima’s high-throughput, low-cost sequencing platform. Together, the companies will deliver efficient, traceable, and unified workflows for multi-omics research and clinical […]

SHENZHEN, China — MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced the launch of the DNBSEQ-T7+, its latest high-throughput sequencer. Designed to meet the rising demand for large-scale genomic research, the T7+ delivers more than 14 Tb/day of data in just 24 hours while offering a smaller footprint, […]

LOS ANGELES — Molecular Instruments® (MI), founded by the inventor of the HCR™ technology, today announces the upcoming release of the HCR™ HiFi Encoder, a breakthrough advance in multiplex immunofluorescence (IF) that enables users to robustly encode best-in-class quantitative signal amplification to their favorite primary antibodies. The HCR™ HiFi Encoder represents a game-changer across the […]

Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history Oracle Health and Life Sciences Summit, ORLANDO, Fla. — DNAnexus, Inc., global provider of the leading enterprise platform for precision health data, today announced its intention to bring precision medicine capabilities to select Oracle Health clinical applications. Incorporating genomic data into the clinical setting […]

London, UK –  Biosearch Technologies, a part of LGC’s Diagnostics and Genomics division and a global leader in life sciences, has signed a Memorandum of Understanding (MoU) with Genolution, a leading Korean-based molecular diagnostics and automation company, to enable LGC’s sbeadexTM Lightning nucleic acid purification chemistry on Genolution’s Nextractor® NX-Duo (NX-Duo) automated platform across Asia […]

Männedorf, Switzerland – The Tecan Group (SIX Swiss Exchange: TECN) today announced a change of leadership in its Partnering Business division. Ralf Griebel, who has served as Head of the Partnering Business division and as a member of the Management Board since April 2020, will be leaving the Company to pursue other opportunities. The Board […]